Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Jan 2026 for Fortress Biotech, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Kevin Lorenz: trading record in brief
All filings by Kevin Lorenz on record concern Fortress Biotech, Inc., in the capacity of board member. We count 5 filings; the first trade dates from 1 January 2022 and the latest from 1 January 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 5 January 2026 came the latest disclosure, a share grant in Fortress Biotech, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kevin Lorenz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
27,322 shares0common stock, par value $0.001SEC:0001772558-26-000002:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000426:0
3,333 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-000913:0
50,000 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-001099:0
50,000 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-22-053584:0
5 of 5 declarations
